Single Dose Pharmacokinetic Study of GB221 in Comparison With Herceptin ®
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: GB221|DRUG: Herceptin
Sponsor: Genor Biopharma Co., Ltd.